Commentary: The small-molecule 'penalty' is a threat to Mass. biotech sector
February 09, 2024 at 05:00 AM EST
The Inflation Reduction Act inadvertently introduced a change in drug-development incentives that could result in distorted decisions about which treatments get developed.
